Dominik Meyer

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Mestex Ag, Karl Storz-Gmbh & Co. Kg, Unversität Zürich. Active years: 2011-2017.

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 4

Average Co-Inventor Count = 1.2

ph-index = 3

Forward Citations = 44(Granted Patents)

Location History:

Zürich, CH (2011)
Zurich, CH (2014 - 2017)

Company Filing History:

Karl Storz-Gmbh & Co. Kg

where one patent can have more than one assignee

Years Active: 2011-2017

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9622737 - Anchor element for knotless fixing of tissue to a bone (2017-04-18),

2. 9044452 - Use of resiniferatoxin (RTX) for producing an agent for treating joint pains and method for applying said agent (2015-06-02),

3. 8703741 - Method of treating articular pain using a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan (2014-04-22),

4. 7964644 - Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means (2011-06-21),

Title: Dominik Meyer: Innovator in Medical Technology

Introduction

Dominik Meyer is a prominent inventor based in Zurich, Switzerland. He has made significant contributions to the field of medical technology, particularly in the development of innovative solutions for joint pain treatment and tissue fixation.

Latest Patents

Meyer holds 4 patents, showcasing his expertise and commitment to advancing medical technology. His latest patents include an anchor element for knotless fixing of tissue to a bone. This anchor element is designed to facilitate the secure attachment of tissue using a suture threaded through the anchor. The body of the anchor features an outer surface with projections, and a transverse bore is located in the distal end section for receiving the threading. Additionally, he has developed a method for using resiniferatoxin (RTX) to produce an agent for treating joint pains. This method involves injecting an agent containing RTX into the affected joint region, providing a targeted approach to pain relief.

Career Highlights

Throughout his career, Dominik Meyer has worked with notable companies such as Mestex AG and Karl Storz GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in medical technology.

Collaborations

Meyer has collaborated with esteemed colleagues, including Christian Gerber and Sascha Berberich. These partnerships have fostered a creative environment that has led to the development of impactful medical solutions.

Conclusion

Dominik Meyer is a distinguished inventor whose work in medical technology continues to influence the industry. His innovative patents and collaborations reflect his dedication to improving patient care and advancing medical practices.